CoChat
Sign Up
Cited by 123Attention Deficit Hyperactivity DisorderPharmacology and Obesity TreatmentPharmaceutical studies and practices

The DOI matches its Crossref record; 4 of the 6 references it cites were found in a registry or an index.

Growth rebound after termination of stimulant drugs

Safer, Daniel J., Allen, Richard P., Barr, Evelyn·1975·The Journal of Pediatrics
DOI 10.1016/s0022-3476(75)80720-7
Open this paper in CoChat — free account

Abstract

To explore further the report of an accelerated weight gain following termination of treatment with a stimulant drug, 66 biannual growth measurements were obtained from 1970 to 1973 on hyperactive schoolchildren who were receiving medication. All received either dextroamphetamine or methylphenidate during the school year; some also received it during the summer. The data revealed that those whose stimulant medication was terminated at the start of summer subsequently grew in weight and height at a significantly greater rate than those who continued to receive medication from June to September. In fact, discontinuance of the medication resulted in a growth rebound for this period which was 15-68% above the age-expected increment.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0022-3476(75)80720-7

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

Sorted by citations

See all 123

Related

See all

Metadata

Authors
Safer, D. J., Allen, R. P., & Barr, E.
Affiliations
Johns Hopkins University (US)
Corresponding author
Safer, Daniel J.
ORCID
Venue
The Journal of Pediatrics
Publisher
Elsevier BV
Published
1975-01
Volume
86
Issue
1
Pages
113-116
ISSN
0022-3476 (ISSN-L)
DOI
10.1016/s0022-3476(75)80720-7
OpenAlex
W2040914596
Cited by
123
References
6
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2022: 2 · 2021: 3 · 2019: 1 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 6
FWCI
10.44
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Journal of Pediatrics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
d-amphetamine, methylphenidate, hyperactive children, weight gain, height growth, ADHD medication
MeSH terms
Adolescent, Body Height, Body Weight, Child, Dextroamphetamine, Female, Humans, Hyperkinesis, Male, Methylphenidate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review